Gatifloxacin-associated hypoglycemia

Journal of Pharmacy Technology

Volumn 18, Issue 6, 2002, Pages 319-320

  Parilo, Miguel A ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CYTOCHROME P450 3A4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GATIFLOXACIN; GLIBENCLAMIDE; LISINOPRIL; PIOGLITAZONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SIMVASTATIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CASE REPORT; DIABETIC NEPHROPATHY; DYSLIPIDEMIA; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PNEUMONIA; VERTEBRAL CANAL STENOSIS;

EID: 0036863820     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512250201800605     Document Type: Article

References (13)

1. Roberge RJ, Kaplan R, Frank R, Fore C. Glyburide-ciprofloxacin interaction with resistant hypoglycemia. Ann Emerg Med 2000;36:160-3.
2. Solomkin JS, Wilson SE, Christou NV, Rutstein OD, Dellinger EP, Bennion RS, et al. Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections. Ann Surg 2001;233:79-87.
3. Grasela DM. Clinical pharmacology of gatifloxacin, a new fluoroquinolone. Clin Infect Dis 2000;31(suppl 2):S51-8.
4. Gatifloxacin and moxifloxacin: Two new fluoroquinolones. Med Lett Drugs Ther 2000;42:15-7.
5. Package Insert. Tequin (Gatifloxacin). Princeton, NJ: Bristol-Myers Squibb, October 2001.
6. Gajjar DA, LaCreta FP, Kollia GD, Stolz RR, Berger S, Smith WB, et al. Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with non-insulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy 2000;20(suppl):76S-86S.
7. Grasela D, LaCreta F, Kollia GD, Randall D, Stoltz R, Berger S. Lack of effect of multiple dose gatifloxacin (GAT) on oral glucose tolerance (OGTT), glucose and insulin homeostasis and glyburide pharmacokinetics (PK) in patients with type 11 non-insulin dependent diabetes mellitus (NIDDM) [abstract 196]. In: Proceedings and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 26-29, 1999:11.
8. Pearson JG, Antal EJ, Raehl CL, Gorsch HK, Craig WA, Albert KS, et al. Pharmacokinetic disposition of 14C-glyburide in patients with varying renal function. Clin Pharmacol Ther 1986;39:318-24.
9. Do ACE inhibitors promote hypoglycemia in diabetic patients? Journal Watch Gen Medicine 1997;1.
10. Morris AD, Boyle BI, McMahon AD, Pearce H, Evans JM, Newton RW, et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care 1997;20:1363-7.
11. The EUCLID Study Group. Randomized placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349:1787-92.
12. Lebovitz HE, Banerji MA. Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 2001;56:265-94.
13. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.